Aflibercept 8 mg every 12 or 16 weeks provides visual and anatomic gains in patients with polypoidal choroidal vasculopathy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results